TTR and cardiac amyloidosis: We therefore sought to determine whether circulating levels of MMPs and TIMPs in a new, larger cohort of cardiac amyloidosis patients would allow us to differentiate between patients with AL‐CMP and those with TTR‐CMP and perhaps aid in further clinical management.